INOVIQ Ltd (ASX:IIQ) (INOVIQ®) is developing and commercialising next-generation exosome capture tools and precision diagnostics to improve the diagnosis and treatment of cancer and other diseases. INOVIQ’s vison is to be a leading exosome and precision diagnostics company delivering nextgeneration products to improve patient health outcomes and help save lives. 1 Contents 2 Chairman and CEO Letter 4 2022 Key Highlights 6 Review of Operations 22 Directors’ Report 33 Auditor’s Independence Declaration 34 Consolidated Statement of Comprehensive Income 35 Consolidated Statement of Financial Position 36 Consolidated Statement of Changes in Equity 37 Consolidated Statement of Cash Flows 38 Notes to the Financial Statements 66 Directors’ Declaration 67 Corporate Governance Statement 68 Independent Auditor’s Report 72 Shareholder Information 1 Annual Report 2022 Contents
RkJQdWJsaXNoZXIy MjE2NDg3